S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
S&P 500   4,122.47 (-0.42%)
DOW   32,774.41 (-0.18%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
NASDAQ:MMSI

Merit Medical Systems - MMSI Stock Forecast, Price & News

$60.52
-0.16 (-0.26%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$60.03
$61.36
50-Day Range
$51.68
$62.10
52-Week Range
$50.46
$73.85
Volume
481,079 shs
Average Volume
360,407 shs
Market Capitalization
$3.43 billion
P/E Ratio
59.33
Dividend Yield
N/A
Price Target
$72.33

Merit Medical Systems MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
19.5% Upside
$72.33 Price Target
Short Interest
Healthy
1.98% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.16
Upright™ Environmental Score
News Sentiment
0.02mentions of Merit Medical Systems in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$627,326 Sold Last Quarter
Proj. Earnings Growth
11.69%
From $2.48 to $2.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.63 out of 5 stars

Medical Sector

133rd out of 1,098 stocks

Surgical & Medical Instruments Industry

11th out of 112 stocks

MMSI stock logo

About Merit Medical Systems (NASDAQ:MMSI) Stock

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.

Merit Medical Systems Trading Up 0.4 %

NASDAQ:MMSI traded up $0.22 during trading on Tuesday, hitting $60.90. The company had a trading volume of 9,745 shares, compared to its average volume of 395,058. The company has a current ratio of 2.52, a quick ratio of 1.33 and a debt-to-equity ratio of 0.22. Merit Medical Systems has a one year low of $50.46 and a one year high of $73.85. The company has a market cap of $3.45 billion, a price-to-earnings ratio of 59.49, a price-to-earnings-growth ratio of 2.20 and a beta of 1.02. The company's fifty day moving average is $55.69 and its 200-day moving average is $59.77.

Merit Medical Systems (NASDAQ:MMSI - Get Rating) last issued its quarterly earnings data on Wednesday, July 27th. The medical instruments supplier reported $0.73 EPS for the quarter, topping the consensus estimate of $0.58 by $0.15. Merit Medical Systems had a net margin of 5.24% and a return on equity of 13.74%. The business had revenue of $294.98 million during the quarter, compared to analyst estimates of $280.55 million. During the same period in the prior year, the business earned $0.62 EPS. The company's revenue for the quarter was up 5.2% on a year-over-year basis. On average, sell-side analysts predict that Merit Medical Systems will post 2.48 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on MMSI shares. Barrington Research dropped their price target on shares of Merit Medical Systems from $82.00 to $78.00 in a research report on Thursday, April 28th. Piper Sandler dropped their price target on shares of Merit Medical Systems from $75.00 to $70.00 in a research report on Friday, July 1st. TheStreet cut shares of Merit Medical Systems from a "b-" rating to a "c+" rating in a research report on Wednesday, May 11th. StockNews.com raised shares of Merit Medical Systems from a "buy" rating to a "strong-buy" rating in a research report on Wednesday, April 13th. Finally, Canaccord Genuity Group dropped their price target on shares of Merit Medical Systems from $74.00 to $67.00 and set a "buy" rating for the company in a research report on Monday, August 1st. One equities research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average price target of $72.33.

Insider Buying and Selling

In related news, Director F. Ann Millner sold 6,378 shares of the stock in a transaction dated Friday, June 3rd. The shares were sold at an average price of $61.92, for a total value of $394,925.76. Following the completion of the transaction, the director now directly owns 27,698 shares in the company, valued at approximately $1,715,060.16. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, Director F. Ann Millner sold 6,378 shares of the stock in a transaction dated Friday, June 3rd. The shares were sold at an average price of $61.92, for a total value of $394,925.76. Following the completion of the transaction, the director now directly owns 27,698 shares in the company, valued at approximately $1,715,060.16. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Neil Peterson sold 4,000 shares of the firm's stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $58.10, for a total transaction of $232,400.00. The disclosure for this sale can be found here. 3.80% of the stock is owned by company insiders.

Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

MMSI Stock News Headlines

Merit Medical Systems, Inc.
See More Headlines
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

MMSI Company Calendar

Last Earnings
7/27/2022
Today
8/09/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:MMSI
CUSIP
58988910
Employees
6,446
Year Founded
1987

Price Target and Rating

Average Stock Price Forecast
$72.33
High Stock Price Forecast
$78.00
Low Stock Price Forecast
$67.00
Forecasted Upside/Downside
+19.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
5 Analysts

Profitability

Net Income
$48.45 million
Pretax Margin
6.20%

Debt

Sales & Book Value

Annual Sales
$1.07 billion
Cash Flow
$4.16 per share
Book Value
$18.42 per share

Miscellaneous

Free Float
54,527,000
Market Cap
$3.43 billion
Optionable
Optionable
Beta
1.02

Social Links















MMSI Stock - Frequently Asked Questions

Should I buy or sell Merit Medical Systems stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Merit Medical Systems in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" MMSI shares.
View MMSI analyst ratings
or view top-rated stocks.

What is Merit Medical Systems' stock price forecast for 2022?

5 Wall Street analysts have issued 1-year price targets for Merit Medical Systems' shares. Their MMSI share price forecasts range from $67.00 to $78.00. On average, they expect the company's share price to reach $72.33 in the next year. This suggests a possible upside of 18.7% from the stock's current price.
View analysts price targets for MMSI
or view top-rated stocks among Wall Street analysts.

How has Merit Medical Systems' stock performed in 2022?

Merit Medical Systems' stock was trading at $62.30 at the beginning of 2022. Since then, MMSI shares have decreased by 2.2% and is now trading at $60.96.
View the best growth stocks for 2022 here
.

When is Merit Medical Systems' next earnings date?

Merit Medical Systems is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our MMSI earnings forecast
.

How were Merit Medical Systems' earnings last quarter?

Merit Medical Systems, Inc. (NASDAQ:MMSI) posted its quarterly earnings results on Wednesday, July, 27th. The medical instruments supplier reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.58 by $0.15. The medical instruments supplier earned $294.98 million during the quarter, compared to the consensus estimate of $280.55 million. Merit Medical Systems had a net margin of 5.24% and a trailing twelve-month return on equity of 13.74%. The company's revenue for the quarter was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.62 EPS.

What guidance has Merit Medical Systems issued on next quarter's earnings?

Merit Medical Systems updated its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share guidance of $2.42-$2.52 for the period, compared to the consensus estimate of $2.48. The company issued revenue guidance of $1.12 billion-$1.14 billion, compared to the consensus revenue estimate of $1.13 billion.

What is Fred P. Lampropoulos' approval rating as Merit Medical Systems' CEO?

158 employees have rated Merit Medical Systems Chief Executive Officer Fred P. Lampropoulos on Glassdoor.com. Fred P. Lampropoulos has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Merit Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Merit Medical Systems investors own include Citigroup (C), OraSure Technologies (OSUR), LightPath Technologies (LPTH), Overstock.com (OSTK), EXFO (EXFO), Energy Transfer (ET), RTI Surgical (RTIX), NVIDIA (NVDA), Under Armour (UA) and Advanced Micro Devices (AMD).

What is Merit Medical Systems' stock symbol?

Merit Medical Systems trades on the NASDAQ under the ticker symbol "MMSI."

Who are Merit Medical Systems' major shareholders?

Merit Medical Systems' stock is owned by many different institutional and retail investors. Top institutional shareholders include Conestoga Capital Advisors LLC (3.68%), Loomis Sayles & Co. L P (1.50%), Emerald Advisers LLC (0.93%), Emerald Mutual Fund Advisers Trust (0.85%), Frontier Capital Management Co. LLC (0.56%) and Assenagon Asset Management S.A. (0.47%). Insiders that own company stock include A Scott Anderson, Brian G Lloyd, David Floyd, David Ming-Teh Liu, Enterprise Associates 14 New, F Ann Millner, Franklin J Miller, Fred P Lampropoulos, Jill Anderson, Joseph Wright, Lynne Ward, Neil Peterson, Nolan E Karras, Raul Jr Parra and Ronald Frost.
View institutional ownership trends
.

How do I buy shares of Merit Medical Systems?

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Merit Medical Systems' stock price today?

One share of MMSI stock can currently be purchased for approximately $60.96.

How much money does Merit Medical Systems make?

Merit Medical Systems (NASDAQ:MMSI) has a market capitalization of $3.46 billion and generates $1.07 billion in revenue each year. The medical instruments supplier earns $48.45 million in net income (profit) each year or $1.02 on an earnings per share basis.

How many employees does Merit Medical Systems have?

Merit Medical Systems employs 6,446 workers across the globe.

Does Merit Medical Systems have any subsidiaries?

The following companies are subsidiares of Merit Medical Systems: Alveolus Inc., Argon Medical Devices Netherlands BV, BSMD Ventures Inc., BioSphere Medical Inc., BioSphere Medical Japan Inc., BioSphere Medical SA, Brightwater Medical Inc., Brightwater Medical Inc., Cianna Medical Inc., DFINE Inc., Dfine Europe GmbH, Fibrovein Holdings Limited, ITL Healthcare Pty Ltd., IntelliMedical Technologies Pty Ltd., LLC Merit Technologies, Merit Holdings Inc., Merit Maquiladora México S. DE R.L. DE C.V., Merit Medical (NRI) Ireland Limited, Merit Medical Africa (Pty) LTD, Merit Medical Asia Company Limited, Merit Medical Australia Pty Ltd., Merit Medical Austria GmbH, Merit Medical Beijing Co. Ltd., Merit Medical Belgium Sprl, Merit Medical Canada Ltd., Merit Medical Coatings B.V., Merit Medical Comercialização Distribuição Importação e Exportação de Produtos Hospitalares LTDA., Merit Medical Denmark A/S, Merit Medical Egypt LLC, Merit Medical Finland Ltd., Merit Medical France SAS, Merit Medical GmbH, Merit Medical Ireland Ltd., Merit Medical Italy S.R.L., Merit Medical Japan KK, Merit Medical Korea Co. Ltd., Merit Medical ME FZ-LLC, Merit Medical Malaysia Sdn. Bhd, Merit Medical Nederland B.V., Merit Medical New Zealand Limited, Merit Medical Norway AS, Merit Medical Portugal S.A., Merit Medical Singapore Holdings Pte. Ltd, Merit Medical Singapore Pte. Ltd., Merit Medical South Africa (Pty) LTD, Merit Medical Spain S.L.Unipersonal, Merit Medical Switzerland AG, Merit Medical Systems AB, Merit Medical Systems India Private Limited, Merit Medical System’s NRI Limited, Merit Medical Turkey Tıbbi Ürünler Ticaret Anonim Şirketi, Merit Medical UK Limited, Merit Mexico Sales S. de R.L. de C.V., Merit Sensor Systems Inc., STD Pharmaceutical (Ireland) Limited, STD Pharmaceutical Products Limited, Thomas Medical Products Inc., Vascular Access Technologies Inc., and Vascular Insights LLC.
Read More

When was Merit Medical Systems founded?

Merit Medical Systems was founded in 1987.

How can I contact Merit Medical Systems?

Merit Medical Systems' mailing address is 1600 WEST MERIT PARK WAY, SOUTH JORDAN UT, 84095. The official website for the company is www.merit.com. The medical instruments supplier can be reached via phone at (801) 253-1600, via email at awright@merit.com, or via fax at 801-253-1652.

This page (NASDAQ:MMSI) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.